<DOC>
	<DOCNO>NCT00386659</DOCNO>
	<brief_summary>Pilot , randomize , parallel , open-label , control , clinical study evaluate virological response plasma extra-plasmatic compartment , together degree kinetics immune reconstitution treatment-naïve patient CD4 count 100 cells/mL , treat tenofovir abacavir together lopinavir efavirenz .</brief_summary>
	<brief_title>Immune Reconstitution naïve HIV Patients With CD4 &lt; 100 Cells/mL When Treated With Lopinavir Efavirenz .</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Abacavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Dideoxynucleosides</mesh_term>
	<criteria>HIVinfection Antiretroviralnaive CD4 cell count 100 cells/mm3 Pregnancy Current opportunistic infection require parenteral therapy Current malignancy require parenteral chemotherapy Any contraindication study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>